Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.

Navari RM, Einhorn LH, Loehrer PJ Sr, Passik SD, Vinson J, McClean J, Chowhan N, Hanna NH, Johnson CS.

Support Care Cancer. 2007 Nov;15(11):1285-91. Epub 2007 Mar 21.

PMID:
17375339
2.

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.

Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E.

Tumori. 2008 Jul-Aug;94(4):447-52. Review.

3.

Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.

Celio L, Agustoni F, Testa I, Dotti K, de Braud F.

Tumori. 2012 May-Jun;98(3):279-86. doi: 10.1700/1125.12393. Review.

4.

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.

Navari RM.

J Support Oncol. 2003 Jul-Aug;1(2):89-103. Review.

PMID:
15352652
5.
6.

Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?

Doggrell SA.

Expert Opin Pharmacother. 2017 Jul;18(10):1019-1026. doi: 10.1080/14656566.2017.1342809. Epub 2017 Jun 19. Review.

PMID:
28612633
7.

Olanzapine for preventing nausea and vomiting induced by moderately and highly emetogenic chemotherapy.

Wang SY, Yang ZJ, Zhang L.

Asian Pac J Cancer Prev. 2014;15(22):9587-92. Review.

8.

Palonosetron: in the prevention of nausea and vomiting.

Yang LP, Scott LJ.

Drugs. 2009 Nov 12;69(16):2257-78. doi: 10.2165/11200980-000000000-00000. Review.

PMID:
19852528
9.

Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Keating GM.

Drugs. 2015 Dec;75(18):2131-41. doi: 10.1007/s40265-015-0512-9. Review.

PMID:
26613606
10.

Emerging drugs for chemotherapy-induced emesis.

Navari RM, Province PS.

Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51. Review.

PMID:
16503832
11.

Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.

Navari RM.

Future Oncol. 2006 Oct;2(5):591-602. Review.

PMID:
17026451
12.

A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Likun Z, Xiang J, Yi B, Xin D, Tao ZL.

Oncologist. 2011;16(2):207-16. doi: 10.1634/theoncologist.2010-0198. Epub 2011 Jan 31. Review.

13.
14.

Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis.

Zhang Y, Yang Y, Zhang Z, Fang W, Kang S, Luo Y, Sheng J, Zhan J, Hong S, Huang Y, Zhou N, Zhao H, Zhang L.

J Natl Cancer Inst. 2016 Oct 30;109(2). pii: djw217. Print 2017 Feb. Review.

PMID:
27795228
15.

Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.

Navari RM.

Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1577-86. doi: 10.1517/17425250903407289. Review.

PMID:
19929251
16.

Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.

Natale JJ.

Hosp Pract (1995). 2015;43(4):226-34. doi: 10.1080/21548331.2015.1077095. Epub 2015 Aug 26. Review.

PMID:
26308912
17.

New antiemetic drugs.

Roila F, Fatigoni S.

Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. Review.

PMID:
16608997
18.

Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.

Navari RM.

Expert Opin Pharmacother. 2014 Dec;15(17):2599-608. doi: 10.1517/14656566.2014.972366. Epub 2014 Oct 17. Review.

PMID:
25323946
19.

Update on the management of chemotherapy-induced nausea and vomiting.

Viale PH.

J Infus Nurs. 2006 Sep-Oct;29(5):283-92. Review.

PMID:
17035890
20.

Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.

Billio A, Morello E, Clarke MJ.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006272. doi: 10.1002/14651858.CD006272.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD006272.

PMID:
20091591

Supplemental Content

Support Center